CFDE Data Portal | Search YPEL5P2

	Label	Description
	YPEL5P2 Gene (Entity type)	ENSG00000271557 - YPEL5 pseudogene 2
	GSE182680 GSE182683 dexamethasone 10 v 13 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE196343 metformin 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE126651 PRMT5 MTAP inhibition 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Pancreas 20-29 vs 70-79 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Spleen 20-29 vs 50-59 Up Gene Set (Entity type)	A Gene Set from GTEx
	OXGR1 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	TAS2R43 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	TAS2R46 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GSE182150 KIT LSD1 MYC inhibition 4 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS

YPEL5P2

ENSG00000271557 - YPEL5 pseudogene 2

GSE182680 GSE182683 dexamethasone 10 v 13 human up

A Gene Set from LINCS

GSE196343 metformin 1 v 0 human up

A Gene Set from LINCS

GSE126651 PRMT5 MTAP inhibition 1 v 2 human dn

A Gene Set from LINCS

GTEx Pancreas 20-29 vs 70-79 Up

A Gene Set from GTEx

GTEx Spleen 20-29 vs 50-59 Up

A Gene Set from GTEx

OXGR1 IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

TAS2R43 IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

TAS2R46 IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

GSE182150 KIT LSD1 MYC inhibition 4 v 3 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.